STUDY of the effects of toxic agents on the liver has given us a considerable body of knowledge about the histological and biochemical abnormalities resulting from the action of specific drugs. Less is known about what happens if these are given concurrently nor do we know whether their individual effects on hepatic tissue are retained or merged with one another. Such studies might well supply new data concerning both their modes of action and also the reactions of liver cells to damage, in the same way as Rous and Larimore's (1920) experiments combining portal vein ligation with bile duct obstruction produced a result unpredictable from the known effects of ligation of each separately.
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In a previous paper (Sutton, 1960 ) the combination of carbon tetrachloride (CC14) and c-naphthyl-isothiocyanate (ANI) was used. This gave disappointing results for there was merely a summation of their individual effects. The present paper describes the action of repeated doses of CC14 on the rat liver already undergoing carcinogenesis by feeding with p-dimethylaminoazobenzene (butter yellow, DAB). In view of the known association between cirrhosis of the liver and hepatic cancer, it was suspected that CC14, which produces liver necrosis as an acute effect and cirrhosis as a chronic, might alter the pattern of carcinogenesis induced by DAB. Also, unlike ANI which acts almost entirely on the bile ducts, both CC14 and DAB affect the hepatic parenchymal cells, and it was wondered how they would respond to this double injury. In a paper dealing mainly with the effects of different diets on liver tumours induced by DAB, Miller et al. (1941) reported that subcutaneous injections of CC14 had no obvious effect on liver tumour production (though CC14 given prior to DAB may have slightly increased the rate of tumour formation).
MATERIALS AND METHODS
One hundred and three adult Wistar albino rats ofboth sexes were used, the average weight at the start-of the experiment was 150 g. The animals were split into three groups: 45 rats received both DAB and CC14, 38 DAB alone and 20 CC14 alone. DAB was mixed with MRC powder 41 in a concentration of 0 06 per cent. CC14 was given by Forbes' (1939) inhalation method once a week commencing two weeks after the rats had started DAB feeding, and continued for 24 weeks except for a gap of 3 weeks following the 14th week when no CC14 was given, though DAB feeding continued. All animals had access to unlimited water. Rats were weighed regularly and killed by excess ether at appropriate intervals throughout the experiment up to 36 weeks; if they were receiving both DAB and CC14 they were killed 7 days after the last inhalation of CC14. Six rats died and were useless for histology because of autolysis. Careful post mortem examinations were made and material taken for histology from liver, spleen, lung and kidney as a routine, together with any other organs appearing abnormal. Sections were cut at 5 It, and stained with Ehrlich's acid haematoxylin and eosin (H. and E.), Van Gieson's method, silver impregnation for reticulin and periodic-acidSchiff (PAS).
RESULTS
Weekly inhalations of CC14 administered to rats already on a DAB-containing diet produced a marked contrast in the early histological changes in the liver by comparison with those induced by DAB alone. When DAB alone is fed, changes occur in both the biliary system and the hepatic parenchyma. The earliest changes are those of bile duct proliferation, which may be extreme giving a cirrhotic-like histological picture plus certain focal bile duct lesions which will be considered in more detail below. Meanwhile, the parenchymal cells undergo progressive alterations in their nuclei and cytoplasm, with the eventual appearance of nodules of hyperplastic liver cells. Finally, after about 6 months malignant tumours arise, the majority of parenchymal cell origin but with some cholangiocarcinomas. The essential differences between the two main groups of rats, those on DAB plus CC14 and those on DAB alone were of a quantitative rather than a qualitative nature. Since no special histological features were discovered which would warrant a detailed pathological description the results will be presented as a comparison between these two groups of animals, using the terminology employed by Opie (1944) and Firminger (1955) in their accounts of DAB carcinogenesis. Even inside each of the two main groups, considerable variation existed from animal to animal in the degree of hepatic change found in rats killed at the same time. Accordingly the findings will be given at three monthly intervals so that the groups are sufficiently big to make the results significant. The third group of rats receiving only weekly inhalations of CC14 showed the typical zonal areas of centrilobular liver necrosis 24 hours after administration of the toxic agent, with complete regeneration over the next 7 days before the next dose. When these rats were killed 10 days after the last of 24 weekly attacks of CC14 induced necrosis, their livers showed no abnormality and in particular no cirrhosis (Fig. 1 ). In the results described below animals on CC14 alone will not be considered further.
Months 1-3.-The most marked difference was the far greater degree of bile duct activity found in animals on DAB plus CC14 compared with those on DAB alone. About one half of the rats receiving the former treatment developed the striking lesion called by Opie (1944) cholangiofibrosis (Table I) . Here foci of hyperplastic bile ducts with frequent mitoses lay in a cellular stroma of young Months 4-6.-By now the majority of rats receiving DAB with CC14 had developed cholangiofibrosis, whereas only one of the animals receiving DAB alone showed this lesion (Table I) . At this time these areas of cholangiofibrosis were larger and the more central bile ducts were less hyperplastic with fewer mitoses and less hyperchromatic than the foci of cholangiofibrosis found during the first three months (Fig. 4) . In places this trend had continued to a dense fibrosis in the middle of the lesion (Fig. 5) , with acellular collections of mucus and small islands of hepatic cells trapped in the fibrous tissue. Once again the animals receiving both toxic agents showed the greater degree of bile duct activity and again there was no difference in the appearance of the parenchymal cells between the two groups. By this time both sets of animals had nodules of actively growing liver cells, with great nuclear variation and quite frequent cell divisions in which occasional abnormal mitoses, in the form of chromosomal bridges, were found. In no case were these nodules sufficiently large or atypical enough to be classified as malignant tumours. A few rats on DAB plus CC14, but none on DAB alone, had enough fibrous tissue formation accompanying the bile duct proliferation, with sufficient distortion of the hepatic architecture on Van Gieson and reticulin staining to warrant the description of portal cirrhosis.
Months 7-9.-From the 24th week until the 36th week when the experiment was concluded the animals in both groups developed malignant tumours of the liver. No metastases were detected, but this was probably because the rats were killed once an abdominal mass was palpated. No significant difference was detected in either the induction time or in the final incidence of liver cancer between the two groups, 11 out of 14 rats on DAB plus CC14 compared with 9 out of 10 rats on DAB alone developing malignant tumours. At this stage, as Table I shows, there was now little difference in the incidence of cholangiofibrosis though these areas were usually larger in animals exposed to both drugs. Regarding the type of liver tumour induced the histological picture showed so much variability in different areas from the same liver that classification was not easy. In general terms, the following conclusions were drawn: (a) In both groups the commonest tumour was one showing a pleomorphic pattern ranging from hepatocarcinoma to the adenohepatoma of other authors.
In a minority there was a definitely cholangiocarcinomatous component. All the tumours showed much necrosis, frequent mitoses with many abnormal forms and tumour giant cells.
(b) Some tumours were of a purely hepatocellular type with a patterln similar to that of embryonic liver and including small islands of haemopoiesis. No bile secretion was detected. These tumours sometimes developed in livers containing nodules of cholangiofibrosis and were so morphologically different from the latter that it was difficult to conceive that they had arisen from them. On the other hand, in rats on DAB alone frank hepatocarcinomas were found in 2 animals in which no cholangiofibrosis at all was present (Fig. 6) .
(c) A minority of the tumours were of a purely cholangiocarcinomatous pattern (Fig. 7) . In at least two rats the histology strongly suggested that a cholangiocarcinoma had arisen from an area of cholangiofibrosis.
Other findings. In both groups the spleen was enlarged to several times the normal size; microscopy showed extreme congestion of the red pulp with large islands of haemopoietic cells. A few rats in both groups developed a chronlic inflammatory lesion in the caecum similar to that described by Orr (1940) . Rats on DAB alone gained more weight (mean +110 g.) than those on DAB plus C(CI4 (mean + 60 g.).
DISCUSSION
In experimental work on liver tumours the nature of the lesion termed cholangiofibrosis has been disputed. The word was coined by Opie (1944) , who implied a precancerous condition in his account of the pathogenesis of the tumours produced by DAB; a similar view was taken by Gupta (1956) (Weiss and Kavanau, 1957; Glinos, 1958) or by the rise in blood levels of growth stimulating factors (Cameron, 1955; Weinbren, 1959) . Abercrombie and Harkness (1951) have shown that following partial hepatectomy parenchymal cells undergo a burst of mitotic activity, maximum at 24 hours, followed at 48 hours by a second smaller peak in bile duct epithelium, sinusoidal cells and probably fibroblasts around portal tracts. This suggests strongly that these non-parenchymal liver cells are also regulated by factors similar to those that control the growth of hepatic parenchymal cells, but that their response is neither so great nor so rapid as the latter. Abercrombie (1957) Miller and Miller, 1953) have suggested that carcinogens act through damage to the specific cellular mechanisms controlling growth. The idea here is that the initial excessive bile duct activity found by giving CC14 together with DAB is accounted for by both substances affecting these growth controlling mechanisms in different ways, CC14 by producing necrosis and DAB by specific damage to these mechanisms short of actual cell death. SUMMARY 1. Rats were exposed to weekly inhalations of CC14 whilst receiving DAB in their diets over a period of months.
2. This resulted in much greater bile duct proliferation and the earlier appearance of cholangiofibrosis than found in rats on DAB alone; but no difference in either the parenchymal cells or in the final production of tumours. Some hepatocarcinomas arose in livers in which no cholangiofibrosis was present. Therefore, in these experiments cholangiofibrosis did not appear to be an essential precursor of liver cancer, although a few instances of cholangiocarcinomas arising in areas of cholangiofibrosis were found.
3. The excessive bile duct activity in rats fed DAB, following weekly CCJ4-induced parenchymal cell necrosis, is compared with the portal cirrhosis found with chronic CCl4 intoxication and the underlying mechanisms discussed.
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